Malignant Neoplasm of the Nasopharynx B022
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2020 |
| Balance of Probabilities SOP | 10 of 2020 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 147
- ICD-10-AM Codes: C11
Brief description
Malignant neoplasm of the nasopharynx is a primary malignancy of the mucosa (lining) of the nasopharynx, which is the space above the soft palate, at the back of the nose.
Confirming the diagnosis
Confirmation of the diagnosis requires histology (from a biopsy or surgical specimen).
The relevant medical practitioner is an Ear, Nose and Throat surgeon.
Additional diagnoses covered by SOP
- squamous cell carcinoma of the nasopharynx
- lymphoepithelioma (obsolete term for nasopharyngeal carcinoma)
- nasopharyngeal carcinoma
- undifferentiated carcinoma of the nasopharynx
Conditions not covered by SOP
- carcinoid tumour of nasopharynx#
- Hodgkin’s lymphoma of the nasopharynx*
- malignant neoplasm of the oropharynx or hypopharynx*
- malignant neoplasm of the sinus (maxillary, ethmoid, frontal or sphenoidal)#
- non-Hodgkin’s lymphoma of the nasopharynx*
- soft tissue sarcoma of the nasopharynx*
- secondary/metastatic cancer/carcinoma involving the nasopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting complaints are headache, diplopia, or facial numbness, caused by cranial nerve involvement, and a mass in the neck, due to cervical node metastases. Nasal obstruction with epistaxis may also occur. Once diagnosis has been confirmed, it may be possible to backdate clinical onset to when relevant symptoms first developed.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Specialist advice will generally be required to determine if worsening due to such inability has occurred.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/m/malignant-neoplasm-nasopharynx-b022-c11
Rulebase for malignant neoplasm of the nasopharynx
<h5><strong>Current RMA Instruments</strong></h5><table border="1" cellpadding="1" cellspacing="1"><tbody><tr><td><a href="http://www.rma.gov.au/assets/SOP/2020/009.pdf"><u>Reasonable Hypothesis SOP</u></a></td><td><span>9 of 2020</span></td></tr><tr><td><a href="http://www.rma.gov.au/assets/SOP/2020/010.pdf"><u>Balance of Probabilities SOP </u></a></td><td><span>10 of 2020</span></td></tr></tbody></table><h5><strong>Changes from previous Instruments</strong></h5><p><drupal-media data-entity-type="media" data-entity-uuid="4a3ff864-c32b-4e5a-846b-2fae13366687" data-view-mode="wysiwyg"></drupal-media></p><p><strong>ICD Coding</strong></p><ul><li>ICD-9-CM Codes: 147</li><li>ICD-10-AM Codes: C11</li></ul><h5>Brief description</h5><p>Malignant neoplasm of the nasopharynx is a primary malignancy of the mucosa (lining) of the nasopharynx, which is the space above the soft palate, at the back of the nose.</p><p><strong>Confirming the diagnosis</strong></p><p>Confirmation of the diagnosis requires histology (from a biopsy or surgical specimen).</p><p>The relevant medical practitioner is an Ear, Nose and Throat surgeon.</p><p><strong>Additional diagnoses covered by SOP</strong></p><ul><li>squamous cell carcinoma of the nasopharynx</li><li>lymphoepithelioma (obsolete term for nasopharyngeal carcinoma)</li><li>nasopharyngeal carcinoma</li><li>undifferentiated carcinoma of the nasopharynx</li></ul><h5><strong>Conditions not covered by SOP</strong></h5><ul><li>carcinoid tumour of nasopharynx<sup><font size="2">#</font></sup></li><li>Hodgkin’s lymphoma of the nasopharynx*</li><li>malignant neoplasm of the oropharynx or hypopharynx*</li><li>malignant neoplasm of the sinus (maxillary, ethmoid, frontal or sphenoidal)<sup><font size="2">#</font></sup></li><li>non-Hodgkin’s lymphoma of the nasopharynx*</li><li>soft tissue sarcoma of the nasopharynx*</li><li>secondary/metastatic cancer/carcinoma involving the nasopharynx (code to primary cancer site)</li></ul><p>* another SOP applies </p><p><sup><font size="2">#</font></sup> non-SOP condition</p><h5><strong>Clinical onset</strong></h5><p>The most common presenting complaints are headache, diplopia, or facial numbness, caused by cranial nerve involvement, and a mass in the neck, due to cervical node metastases. Nasal obstruction with epistaxis may also occur. Once diagnosis has been confirmed, it may be possible to backdate clinical onset to when relevant symptoms first developed. </p><p><strong>Clinical worsening</strong></p><p>The only worsening factor is for inability to obtain appropriate clinical management. Specialist advice will generally be required to determine if worsening due to such inability has occurred.</p><p> </p>
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/rulebase-malignant-neoplasm-nasopharynx
Cigar smoking
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2020 |
| Balance of Probabilities SOP | 10 of 2020 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 147
- ICD-10-AM Codes: C11
Brief description
Malignant neoplasm of the nasopharynx is a primary malignancy of the mucosa (lining) of the nasopharynx, which is the space above the soft palate, at the back of the nose.
Confirming the diagnosis
Confirmation of the diagnosis requires histology (from a biopsy or surgical specimen).
The relevant medical practitioner is an Ear, Nose and Throat surgeon.
Additional diagnoses covered by SOP
- squamous cell carcinoma of the nasopharynx
- lymphoepithelioma (obsolete term for nasopharyngeal carcinoma)
- nasopharyngeal carcinoma
- undifferentiated carcinoma of the nasopharynx
Conditions not covered by SOP
- carcinoid tumour of nasopharynx#
- Hodgkin’s lymphoma of the nasopharynx*
- malignant neoplasm of the oropharynx or hypopharynx*
- malignant neoplasm of the sinus (maxillary, ethmoid, frontal or sphenoidal)#
- non-Hodgkin’s lymphoma of the nasopharynx*
- soft tissue sarcoma of the nasopharynx*
- secondary/metastatic cancer/carcinoma involving the nasopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting complaints are headache, diplopia, or facial numbness, caused by cranial nerve involvement, and a mass in the neck, due to cervical node metastases. Nasal obstruction with epistaxis may also occur. Once diagnosis has been confirmed, it may be possible to backdate clinical onset to when relevant symptoms first developed.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Specialist advice will generally be required to determine if worsening due to such inability has occurred.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-nasopharynx-b022-c11/rulebase-malignant-neoplasm-nasopharynx/cigar-smoking
Cigarette smoking
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2020 |
| Balance of Probabilities SOP | 10 of 2020 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 147
- ICD-10-AM Codes: C11
Brief description
Malignant neoplasm of the nasopharynx is a primary malignancy of the mucosa (lining) of the nasopharynx, which is the space above the soft palate, at the back of the nose.
Confirming the diagnosis
Confirmation of the diagnosis requires histology (from a biopsy or surgical specimen).
The relevant medical practitioner is an Ear, Nose and Throat surgeon.
Additional diagnoses covered by SOP
- squamous cell carcinoma of the nasopharynx
- lymphoepithelioma (obsolete term for nasopharyngeal carcinoma)
- nasopharyngeal carcinoma
- undifferentiated carcinoma of the nasopharynx
Conditions not covered by SOP
- carcinoid tumour of nasopharynx#
- Hodgkin’s lymphoma of the nasopharynx*
- malignant neoplasm of the oropharynx or hypopharynx*
- malignant neoplasm of the sinus (maxillary, ethmoid, frontal or sphenoidal)#
- non-Hodgkin’s lymphoma of the nasopharynx*
- soft tissue sarcoma of the nasopharynx*
- secondary/metastatic cancer/carcinoma involving the nasopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting complaints are headache, diplopia, or facial numbness, caused by cranial nerve involvement, and a mass in the neck, due to cervical node metastases. Nasal obstruction with epistaxis may also occur. Once diagnosis has been confirmed, it may be possible to backdate clinical onset to when relevant symptoms first developed.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Specialist advice will generally be required to determine if worsening due to such inability has occurred.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-nasopharynx-b022-c11/rulebase-malignant-neoplasm-nasopharynx/cigarette-smoking
Exposure to mustard gas
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2020 |
| Balance of Probabilities SOP | 10 of 2020 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 147
- ICD-10-AM Codes: C11
Brief description
Malignant neoplasm of the nasopharynx is a primary malignancy of the mucosa (lining) of the nasopharynx, which is the space above the soft palate, at the back of the nose.
Confirming the diagnosis
Confirmation of the diagnosis requires histology (from a biopsy or surgical specimen).
The relevant medical practitioner is an Ear, Nose and Throat surgeon.
Additional diagnoses covered by SOP
- squamous cell carcinoma of the nasopharynx
- lymphoepithelioma (obsolete term for nasopharyngeal carcinoma)
- nasopharyngeal carcinoma
- undifferentiated carcinoma of the nasopharynx
Conditions not covered by SOP
- carcinoid tumour of nasopharynx#
- Hodgkin’s lymphoma of the nasopharynx*
- malignant neoplasm of the oropharynx or hypopharynx*
- malignant neoplasm of the sinus (maxillary, ethmoid, frontal or sphenoidal)#
- non-Hodgkin’s lymphoma of the nasopharynx*
- soft tissue sarcoma of the nasopharynx*
- secondary/metastatic cancer/carcinoma involving the nasopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting complaints are headache, diplopia, or facial numbness, caused by cranial nerve involvement, and a mass in the neck, due to cervical node metastases. Nasal obstruction with epistaxis may also occur. Once diagnosis has been confirmed, it may be possible to backdate clinical onset to when relevant symptoms first developed.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Specialist advice will generally be required to determine if worsening due to such inability has occurred.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-nasopharynx-b022-c11/rulebase-malignant-neoplasm-nasopharynx/exposure-mustard-gas
Heavy occupational exposure to wood dust
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2020 |
| Balance of Probabilities SOP | 10 of 2020 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 147
- ICD-10-AM Codes: C11
Brief description
Malignant neoplasm of the nasopharynx is a primary malignancy of the mucosa (lining) of the nasopharynx, which is the space above the soft palate, at the back of the nose.
Confirming the diagnosis
Confirmation of the diagnosis requires histology (from a biopsy or surgical specimen).
The relevant medical practitioner is an Ear, Nose and Throat surgeon.
Additional diagnoses covered by SOP
- squamous cell carcinoma of the nasopharynx
- lymphoepithelioma (obsolete term for nasopharyngeal carcinoma)
- nasopharyngeal carcinoma
- undifferentiated carcinoma of the nasopharynx
Conditions not covered by SOP
- carcinoid tumour of nasopharynx#
- Hodgkin’s lymphoma of the nasopharynx*
- malignant neoplasm of the oropharynx or hypopharynx*
- malignant neoplasm of the sinus (maxillary, ethmoid, frontal or sphenoidal)#
- non-Hodgkin’s lymphoma of the nasopharynx*
- soft tissue sarcoma of the nasopharynx*
- secondary/metastatic cancer/carcinoma involving the nasopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting complaints are headache, diplopia, or facial numbness, caused by cranial nerve involvement, and a mass in the neck, due to cervical node metastases. Nasal obstruction with epistaxis may also occur. Once diagnosis has been confirmed, it may be possible to backdate clinical onset to when relevant symptoms first developed.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Specialist advice will generally be required to determine if worsening due to such inability has occurred.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-nasopharynx-b022-c11/rulebase-malignant-neoplasm-nasopharynx/heavy-occupational-exposure-wood-dust
Infection with Epstein-Barr virus
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2020 |
| Balance of Probabilities SOP | 10 of 2020 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 147
- ICD-10-AM Codes: C11
Brief description
Malignant neoplasm of the nasopharynx is a primary malignancy of the mucosa (lining) of the nasopharynx, which is the space above the soft palate, at the back of the nose.
Confirming the diagnosis
Confirmation of the diagnosis requires histology (from a biopsy or surgical specimen).
The relevant medical practitioner is an Ear, Nose and Throat surgeon.
Additional diagnoses covered by SOP
- squamous cell carcinoma of the nasopharynx
- lymphoepithelioma (obsolete term for nasopharyngeal carcinoma)
- nasopharyngeal carcinoma
- undifferentiated carcinoma of the nasopharynx
Conditions not covered by SOP
- carcinoid tumour of nasopharynx#
- Hodgkin’s lymphoma of the nasopharynx*
- malignant neoplasm of the oropharynx or hypopharynx*
- malignant neoplasm of the sinus (maxillary, ethmoid, frontal or sphenoidal)#
- non-Hodgkin’s lymphoma of the nasopharynx*
- soft tissue sarcoma of the nasopharynx*
- secondary/metastatic cancer/carcinoma involving the nasopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting complaints are headache, diplopia, or facial numbness, caused by cranial nerve involvement, and a mass in the neck, due to cervical node metastases. Nasal obstruction with epistaxis may also occur. Once diagnosis has been confirmed, it may be possible to backdate clinical onset to when relevant symptoms first developed.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Specialist advice will generally be required to determine if worsening due to such inability has occurred.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-nasopharynx-b022-c11/rulebase-malignant-neoplasm-nasopharynx/infection-epstein-barr-virus
No appropriate clinical management for malignant neoplasm of nasopharynx
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2020 |
| Balance of Probabilities SOP | 10 of 2020 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 147
- ICD-10-AM Codes: C11
Brief description
Malignant neoplasm of the nasopharynx is a primary malignancy of the mucosa (lining) of the nasopharynx, which is the space above the soft palate, at the back of the nose.
Confirming the diagnosis
Confirmation of the diagnosis requires histology (from a biopsy or surgical specimen).
The relevant medical practitioner is an Ear, Nose and Throat surgeon.
Additional diagnoses covered by SOP
- squamous cell carcinoma of the nasopharynx
- lymphoepithelioma (obsolete term for nasopharyngeal carcinoma)
- nasopharyngeal carcinoma
- undifferentiated carcinoma of the nasopharynx
Conditions not covered by SOP
- carcinoid tumour of nasopharynx#
- Hodgkin’s lymphoma of the nasopharynx*
- malignant neoplasm of the oropharynx or hypopharynx*
- malignant neoplasm of the sinus (maxillary, ethmoid, frontal or sphenoidal)#
- non-Hodgkin’s lymphoma of the nasopharynx*
- soft tissue sarcoma of the nasopharynx*
- secondary/metastatic cancer/carcinoma involving the nasopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting complaints are headache, diplopia, or facial numbness, caused by cranial nerve involvement, and a mass in the neck, due to cervical node metastases. Nasal obstruction with epistaxis may also occur. Once diagnosis has been confirmed, it may be possible to backdate clinical onset to when relevant symptoms first developed.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Specialist advice will generally be required to determine if worsening due to such inability has occurred.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-nasopharynx-b022-c11/rulebase-malignant-neoplasm-nasopharynx/no-appropriate-clinical-management-malignant-neoplasm-nasopharynx
Pipe smoking
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2020 |
| Balance of Probabilities SOP | 10 of 2020 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 147
- ICD-10-AM Codes: C11
Brief description
Malignant neoplasm of the nasopharynx is a primary malignancy of the mucosa (lining) of the nasopharynx, which is the space above the soft palate, at the back of the nose.
Confirming the diagnosis
Confirmation of the diagnosis requires histology (from a biopsy or surgical specimen).
The relevant medical practitioner is an Ear, Nose and Throat surgeon.
Additional diagnoses covered by SOP
- squamous cell carcinoma of the nasopharynx
- lymphoepithelioma (obsolete term for nasopharyngeal carcinoma)
- nasopharyngeal carcinoma
- undifferentiated carcinoma of the nasopharynx
Conditions not covered by SOP
- carcinoid tumour of nasopharynx#
- Hodgkin’s lymphoma of the nasopharynx*
- malignant neoplasm of the oropharynx or hypopharynx*
- malignant neoplasm of the sinus (maxillary, ethmoid, frontal or sphenoidal)#
- non-Hodgkin’s lymphoma of the nasopharynx*
- soft tissue sarcoma of the nasopharynx*
- secondary/metastatic cancer/carcinoma involving the nasopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting complaints are headache, diplopia, or facial numbness, caused by cranial nerve involvement, and a mass in the neck, due to cervical node metastases. Nasal obstruction with epistaxis may also occur. Once diagnosis has been confirmed, it may be possible to backdate clinical onset to when relevant symptoms first developed.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Specialist advice will generally be required to determine if worsening due to such inability has occurred.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-nasopharynx-b022-c11/rulebase-malignant-neoplasm-nasopharynx/pipe-smoking
Smoking tobacco products - material contribution
Current RMA Instruments
| Reasonable Hypothesis SOP | 9 of 2020 |
| Balance of Probabilities SOP | 10 of 2020 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 147
- ICD-10-AM Codes: C11
Brief description
Malignant neoplasm of the nasopharynx is a primary malignancy of the mucosa (lining) of the nasopharynx, which is the space above the soft palate, at the back of the nose.
Confirming the diagnosis
Confirmation of the diagnosis requires histology (from a biopsy or surgical specimen).
The relevant medical practitioner is an Ear, Nose and Throat surgeon.
Additional diagnoses covered by SOP
- squamous cell carcinoma of the nasopharynx
- lymphoepithelioma (obsolete term for nasopharyngeal carcinoma)
- nasopharyngeal carcinoma
- undifferentiated carcinoma of the nasopharynx
Conditions not covered by SOP
- carcinoid tumour of nasopharynx#
- Hodgkin’s lymphoma of the nasopharynx*
- malignant neoplasm of the oropharynx or hypopharynx*
- malignant neoplasm of the sinus (maxillary, ethmoid, frontal or sphenoidal)#
- non-Hodgkin’s lymphoma of the nasopharynx*
- soft tissue sarcoma of the nasopharynx*
- secondary/metastatic cancer/carcinoma involving the nasopharynx (code to primary cancer site)
* another SOP applies
# non-SOP condition
Clinical onset
The most common presenting complaints are headache, diplopia, or facial numbness, caused by cranial nerve involvement, and a mass in the neck, due to cervical node metastases. Nasal obstruction with epistaxis may also occur. Once diagnosis has been confirmed, it may be possible to backdate clinical onset to when relevant symptoms first developed.
Clinical worsening
The only worsening factor is for inability to obtain appropriate clinical management. Specialist advice will generally be required to determine if worsening due to such inability has occurred.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-nasopharynx-b022-c11/rulebase-malignant-neoplasm-nasopharynx/smoking-tobacco-products-material-contribution